Skip to main content
4SC AG logo

4SC AG — Investor Relations & Filings

Ticker · VSC ISIN · DE000A3E5C40 LEI · 391200QOKN7LGVP0RQ86 F Manufacturing
Open in API
Filings indexed 719 across all filing types
Latest filing 2007-06-21 Regulatory Filings
Country DE Germany
Listing F VSC

About 4SC AG

https://www.4sc.com/

4SC AG is a biopharmaceutical company that formerly focused on the research and development of small-molecule drugs for cancer treatment. The company's strategy centered on addressing diseases with high unmet medical needs by developing innovative therapies that targeted epigenetic mechanisms of action. According to the company's official statements, it currently has no products under development and no operational business.

Recent filings

Filing Released Lang Actions
4SC AG achieves proof of concept for drug candidate SC12267
Regulatory Filings Classification · 95% confidence The document is a press release dated June 21, 2007, detailing positive preclinical results ('proof of concept') for a drug candidate (SC12267) in treating chronic inflammatory bowel diseases. It discusses clinical development status (Phase IIa study for rheumatoid arthritis mentioned), market potential, and scientific background. This content is characteristic of an announcement regarding research progress and pipeline updates, rather than a formal regulatory filing like a 10-K, an earnings release (ER), or a formal investor presentation (IP). Since it is a news announcement about scientific/development progress, it fits best under the general 'Regulatory Filings' (RNS) category as a corporate news release that doesn't fit the more specific financial or governance codes. It is not a formal report itself, nor is it a management discussion or earnings summary.
2007-06-21 English
4SC AG erzielt Proof of Concept fur Medikamentenkandidaten SC12267 im Bereich chronisch entzundlicher Darmerkrankungen
Earnings Release Classification · 99% confidence The document is a press release dated June 21, 2007, detailing positive preclinical 'Proof of Concept' results for a drug candidate (SC12267) in treating inflammatory bowel diseases. It discusses clinical trial progress, market potential, and provides background on the disease and the company (4SC AG). This content aligns best with an announcement regarding business development, scientific milestones, or general corporate news that isn't a formal financial report (like 10-K or IR) or a specific regulatory filing like insider trading or dividend notice. Since it is a news release announcing a significant business/scientific update, it fits the general category of an Earnings Release (ER) if it were quarterly results, but here it is a specific scientific/pipeline update. Given the options, and recognizing this is a news announcement about operational progress rather than a formal financial filing, it most closely resembles an Earnings Release (ER) in format (a press release announcing key operational/scientific news) or potentially a Regulatory Filing (RNS) if no better fit exists. However, ER is often used for key operational highlights outside of mandated financial reporting periods. Since it is a news announcement about a scientific milestone, and not a formal financial report, 'ER' is the closest fit for a key operational update announcement, although 'RNS' is a strong fallback. Given the context of a major scientific milestone announcement, I will classify it as an 'ER' as it serves as a primary communication of key company progress to the market, similar to how an earnings release communicates financial progress. Q2 2007
2007-06-21 German
DGAP-DD: 4SC AG english
Director's Dealing Classification · 100% confidence The document explicitly uses the header "Directors’ Dealings" and details a transaction (Purchase of 5000 shares) by an individual identified as holding a managerial responsibility position ('Member of an administrative or supervisory body'). This directly corresponds to the definition of Director's Dealing, which is classified under the code DIRS.
2007-06-05 English
DGAP-DD: 4SC AG english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a 'Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG'. It details a transaction (Purchasing and exercising of options) by a 'Member of an administrative or supervisory body' (Jörg Neermann). This content directly matches the definition for Director's Dealing reports.
2007-06-05 English
Release according to Article 26a, Section 1 WpHG [Securities Trading Act] with the aim of a Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is very short (1082 characters) and explicitly states it is a 'Total voting rights announcement' according to Article 26a, Section 1 WpHG. It announces the total number of voting rights as of the end of May 2007. This type of announcement, which reports on the total number of shares carrying voting rights, is a specific regulatory disclosure. Among the provided codes, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is the most appropriate fit for reporting on the total voting rights structure, even if it's not the final result of a specific vote, as it relates directly to the voting power structure.
2007-05-31 English
Declaration of Voting Results & Voting Rights Announcements 2007
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Voting Rights Announcements' and explicitly states it is a 'Veröffentlichung einer Stimmrechtsmitteilung' (Publication of a voting rights notification). It details changes in the percentage of voting rights held by Deutsche Bank Aktiengesellschaft's subsidiary (DWS Investment GmbH) in 4SC AG, referencing German securities law (§ 26 Abs. 1 WpHG, § 21 Abs. 1 WpHG). This directly corresponds to the definition of Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder votes and related notifications, although the primary focus here is the change in voting rights thresholds.
2007-05-25 German

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.